AirSculpt Technologies, Inc. (AIRS) has a MoatMap StockRank of 30/100 based on Quality (42/100), Value (29/100), and Momentum (47/100) factor scores. The current signal is SELL. AirSculpt Technologies provides body contouring procedures. It is highly exposed to cyclical consumer discretionary spending and lacks the structural, non-discretionary demand signals we look for.
AirSculpt Technologies, Inc. operates a network of body contouring and fat removal centers, utilizing its proprietary AirSculpt technology for minimally invasive procedures. The company benefits from its unique, patented AirSculpt technology, offering a distinct and less invasive alternative to traditional liposuction, leading to high patient satisfaction. It is a specialized healthcare services provider with a focus on aesthetic procedures, leveraging its proprietary technology and a direct-to-consumer marketing model.
| Price | $5.28 |
| Market Cap | $391M |
| P/E (Forward) | -285.50 |
| Price/Book | 4.02 |
| Return on Equity | -12.6% |
| Return on Invested Capital | -7.3% |
| Debt/Equity | 70.83 |
| Gross Margin | 66.1% |
| Operating Margin | -4.6% |
| Revenue Growth | 0.0% |
| Free Cash Flow | $13M |
AirSculpt Technologies, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).